CORAL GABLES, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today reported that its sub-licensee in Japan, DyDo Pharma, Inc.,…

Finance

Markets

Fintech

Real Estate

Latest News

View More
© 2025 The Business Times. All Rights Reserved.